Niraparib hydrochlorideProduct ingredient for Niraparib

Name
Niraparib hydrochloride
Drug Entry
Niraparib

Niraparib is an orally active poly (ADP-ribose) polymerase (PARP) inhibitor. By blocking the enzymes responsible for DNA repair, niraparib induces cytotoxicity in cancer cells.6 Niraparib is selective towards PARP-1 and PARP-2.2 First approved by the FDA on March 27, 2017,3 niraparib is used to treat epithelial ovarian, fallopian tube, or primary peritoneal cancer.6 Niraparib was approved by the European Commission on November 16, 2017 7 and by Health Canada on June 27, 2019.8

Accession Number
DBSALT002076
Structure
Synonyms
Not Available
UNII
L4JFC1PHCI
CAS Number
1038915-64-8
Weight
Average: 356.85
Monoisotopic: 356.140389
Chemical Formula
C19H21ClN4O
InChI Key
YXYDNYFWAFBCAN-PFEQFJNWSA-N
InChI
InChI=1S/C19H20N4O.ClH/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14;/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24);1H/t14-;/m1./s1
IUPAC Name
2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide hydrochloride
SMILES
Cl.NC(=O)C1=CC=CC2=CN(N=C12)C1=CC=C(C=C1)[C@@H]1CCCNC1
ChemSpider
32700147
Predicted Properties
PropertyValueSource
Water Solubility0.0149 mg/mLALOGPS
logP2.45ALOGPS
logP2.47Chemaxon
logS-4.3ALOGPS
pKa (Strongest Acidic)14.03Chemaxon
pKa (Strongest Basic)10.1Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area72.94 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity94.92 m3·mol-1Chemaxon
Polarizability36.41 Å3Chemaxon
Number of Rings4Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon